Comparison of 1-year Major Adverse Cardiac Events in Patients Undergoing Primary Percutaneous Coronary Intervention Receiving Intracoronary Bolus Only Versus Intracoronary Bolus Plus Infusion of Glycoprotein IIb/IIIa Inhibitors-Reference-Cited by-同舟云学术

Comparison of 1-year Major Adverse Cardiac Events in Patients Undergoing Primary Percutaneous Coronary Intervention Receiving Intracoronary Bolus Only Versus Intracoronary Bolus Plus Infusion of Glycoprotein IIb/IIIa Inhibitors

Published:2016-09 Issue:3 Volume:15 Page:89-94
ISSN:1535-282X
Container-title:Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine
language:en
Short-container-title:

Author:

Kassaian Seyed Ebrahim,Fathi Yadollah,Lotfi-Tokaldany Masoumeh,Salarifar Mojtaba,Alidoosti Mohammad,Haji-Zeinali Ali-Mohammad,Aghajani Hassan,Amirzadegan Alireza,Nozari Younes,Mortazavi Seyedeh Hamideh,Jalali Arash,Saroukhani Sepideh

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.;Kushner;J Am Coll Cardiol,2009

2. Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials.;Stone;J Am Coll Cardiol,2015

3. Myocardial no-reflow in humans.;Niccoli;J Am Coll Cardiol,2009

4. Comparative effectiveness of upstream glycoprotein IIb/IIIa inhibitors in patients with moderate-and high-risk acute coronary syndromes: an acute catheterization and urgent intervention triage strategy (ACUITY) substudy.;Nazif;Am Heart J,2014

5. Intracoronary glycoprotein IIb/IIIa inhibitor infusion via a perfusion coronary catheter to decrease thrombus burden: results from the ClearWay™ multicenter registry.;Maluenda;Cardiovasc Revasc Med,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Double-Blinded Randomized Controlled Trial Comparing Eptifibatide Bolus Only Versus Bolus Plus Infusion In Patients Undergoing Primary Percutaneous Coronary Intervention For ST-Elevation Myocardial Infarction;Cardiovascular Revascularization Medicine;2023-06

2. Impact of type D personality on major adverse cardiac events in patients undergoing percutaneous coronary intervention: The mediating role of cognitive appraisal and coping style;Journal of Psychosomatic Research;2020-09

3. Comparison of In-Hospital Bleeding and Cardiovascular Events with High-Dose Bolus Tirofiban and Shortened Infusion to Short-Duration Eptifibatide as Adjunctive Therapy for Percutaneous Coronary Intervention;The American Journal of Cardiology;2019-01

4. Efficacy of alogliptin combined with motor imagery under hyperbaric oxygen in diabetic nephropathy with silent cerebral infarction;Biomedical Reports;2017-09-14